| This Week’s News | The 2023 Cardiovascular Business Salary and Job Satisfaction Report is here! We surveyed cardiologists, interventional cardiologists, nurses, service line mangers, coders and others in the industry about several topics, including compensation, burnout, EHRs and much more. The 2023 Cardiovascular Business Salary and Job Satisfaction Report is here! We surveyed cardiologists, interventional cardiologists, nurses, service line mangers, coders and others in the industry about several topics, including compensation, burnout, EHRs and much more. | |
| The new-look devices are soft, flexible, transparent and roughly the size of a postage stamp. The new-look devices are soft, flexible, transparent and roughly the size of a postage stamp. | |
| Advanced cardiac imager Roosha Parikh, MD, explained that cardiac amyloidosis is regularly misdiagnosed. It can often be identified in echocardiography results, however, if physicians know how to identify it. Advanced cardiac imager Roosha Parikh, MD, explained that cardiac amyloidosis is regularly misdiagnosed. It can often be identified in echocardiography results, however, if physicians know how to identify it. | |
| American Society of Echocardiography President Stephen Little, MD, says several trends and technologies are coming together at once, leading to renewed interest in echo. American Society of Echocardiography President Stephen Little, MD, says several trends and technologies are coming together at once, leading to renewed interest in echo. | |
| After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices. After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices. | |
| “It's very important,” one cardiologist said. “This is a life-saving test and it's very frustrating that we can't access the medication.” “It's very important,” one cardiologist said. “This is a life-saving test and it's very frustrating that we can't access the medication.” | |
| Versanis, founded in 2021 by a venture capital firm, is primarily known as the company behind the obesity drug bimagrumab. Versanis, founded in 2021 by a venture capital firm, is primarily known as the company behind the obesity drug bimagrumab. | |
| The American Society of Echocardiography recognized the lack of training and standardization for point-of-care ultrasound users and decided to do something about it. The American Society of Echocardiography recognized the lack of training and standardization for point-of-care ultrasound users and decided to do something about it. | |
| It is becoming more and more important, researchers noted, to examine the lifetime management of patients who undergo aortic valve replacement. It is becoming more and more important, researchers noted, to examine the lifetime management of patients who undergo aortic valve replacement. | |
| |
|
| | |
|